In a systematic review, Wong et al., 2021 concluded that there is evidence in the literature on the RLN-3/RXFP3 to promote arousal and suppress anxiety- and depression-like behavior, but this field lacks high-quality clinical studies [301]. The gene discussed is RXFP3; the disease is depressive symptom measurement.